According to the new research report published by Precedence Research, titled “Animal Vaccine Market (By Product Type: Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines; By Animal Type: Livestock, Companion; By Route of Administration: Subcutaneous, Intramuscular, Intranasal; By End User: Hospital, clinics) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032 (By Product: Traditional, Advanced; By Application: Pottery, Tiles, Abrasives, Sanitary wave, Bricks & pipes, Others; By End User: Medical, Industrial, Building & Construction, Others) – Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2032”, the global animal vaccine market size is expected to be worth around US$ 3 billion by 2032 and is poised to record a yearly growth rate of 6% from 2023 to 2032. The study investigates several elements and their consequences on the growth of the all-wheel drive market.
This report focuses on animal vaccine market volume and value at the global level, regional level and company level. From a global perspective, this report represents the overall animal vaccine market size by analysing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, the Middle East & Africa, Latin America, etc.
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2032. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Download a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2958
The study also provides important advancements in organic and inorganic growth strategies in the worldwide animal vaccine market. A lot of corporations are prioritizing new launches, product approvals, and other business expansion techniques. In addition, the report offers profiles of animal vaccine market firms and market strategies. Furthermore, the research focuses on top industry participants, providing information such as company profiles, components and services offered, recent financial data, and key developments.
Animal Vaccine Market Report Scope
| Report Coverage | Details |
| Market Size in 2023 | USD 15.69 Billion |
| Market Size by 2032 | USD 36.91 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 9.97% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product Type, By Animal Type, By Route of Administration, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Also read: Smart Sensors Market Size US$ 231.04 Billion by 2032
Market Key Players
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the animal vaccine market.
Some of the prominent players in the animal vaccine market include
- Merck & Co., Inc.
- Zoetis
- Boehringer Ingelheim International GmbH
- Virbac
- Biogénesis Bagó
- Indian Immunologicals Ltd.
- Elanco
- Ceva
- Phibro Animal Health Corporation
- Neogen Corporation
- Intas Pharmaceuticals Ltd.
- Ourofino Saúde Animal
Animal Vaccine Market Segmentations
By Product Type
- Attenuated Live Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- DNA Vaccines
- Recombinant Vaccines
By Animal Type
- Livestock
- Poultry
- Aqua
- Ruminants
- Swine
- Companion
- Canine
- Feline
By Route of Administration
- Subcutaneous
- Intramuscular
- Intranasal
By End User
- Hospital
- clinics
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Report Objectives
- To define, segment, and project the global market size for animal vaccine market
- To understand the structure of the market by identifying its various sub-segments
- To provide detailed information about the key factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
- To analyse the micro-markets, with respect to individual growth trends, future prospects, and their contributions to the total market
- To project the size of the market and its submarkets, in terms of value, with respect to global. (along with their respective key countries)
- To profile key players and comprehensively analyse their core competencies
- To understand the competitive landscape and identify major growth strategies adopted by players across the globe.
- To analyse the competitive developments such as expansions & investments, new product launches, mergers & acquisitions, joint ventures, and agreements
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Animal Vaccine Market
5.1. COVID-19 Landscape: Animal Vaccine Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Animal Vaccine Market, By Product Type
8.1. Animal Vaccine Market Revenue and Volume Forecast, by Product Type, 2023-2032
8.1.1. Attenuated Live Vaccines
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Inactivated Vaccines
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Subunit Vaccines
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
8.1.4. DNA Vaccines
8.1.4.1. Market Revenue and Volume Forecast (2020-2032)
8.1.5. Recombinant Vaccines
8.1.5.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Animal Vaccine Market, By Animal Type
9.1. Animal Vaccine Market Revenue and Volume Forecast, by Animal Type, 2023-2032
9.1.1. Livestock
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Companion
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Animal Vaccine Market, By Route of Administration
10.1. Animal Vaccine Market Revenue and Volume Forecast, by Route of Administration, 2023-2032
10.1.1. Subcutaneous
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Intramuscular
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Intranasal
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Animal Vaccine Market, By End User
11.1. Animal Vaccine Market Revenue and Volume Forecast, by End User, 2023-2032
11.1.1. Hospital
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. clinics
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Animal Vaccine Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End User (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product Type (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Animal Type (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Route of Administration (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End User (2020-2032)
Chapter 13. Company Profiles
13.1. Merck & Co., Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Zoetis
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Boehringer Ingelheim International GmbH
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Virbac
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Biogénesis Bagó
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Indian Immunologicals Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Elanco
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Ceva
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Phibro Animal Health Corporation
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Neogen Corporation
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Why should you invest in this report?
If you are aiming to enter the global animal vaccine market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for animal vaccine are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2023-2030 so that you can plan your strategies to enter this market accordingly.
Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
